SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-19-000259
Filing Date
2019-02-19
Accepted
2019-02-19 15:39:05
Documents
45
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q angiosoma20181231_10q.htm 10-Q 571096
2 EXHIBIT 31.1 ex_134709.htm EX-31.1 8684
3 EXHIBIT 32.1 ex_134710.htm EX-32.1 5776
10 angiosoma20181231_10qimg001.jpg GRAPHIC 7214
  Complete submission text file 0001185185-19-000259.txt   2314897

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT soan-20181231.xml EX-101.INS 289184
5 XBRL TAXONOMY EXTENSION SCHEMA soan-20181231.xsd EX-101.SCH 27974
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE soan-20181231_cal.xml EX-101.CAL 21275
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE soan-20181231_def.xml EX-101.DEF 150277
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE soan-20181231_lab.xml EX-101.LAB 179088
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE soan-20181231_pre.xml EX-101.PRE 150851
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55072 | Film No.: 19614816
SIC: 2834 Pharmaceutical Preparations